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We examined in vitro e¡ects of 17b-estradiol on H2O2-
induced apoptosis in human keratinocytes. 17b-estradiol
prevented the H2O2-induced apoptosis. H2O2 de-
creased, whereas 17b-estradiol increased Bcl-2 protein
and mRNA levels in keratinocytes, and H2O2 plus 17b-
estradiol led to basal levels. Overexpression of Bcl-2
protected keratinocytes against H2O2-induced apopto-
sis, indicating the anti-apoptotic e¡ect of Bcl-2. H2O2
suppressed, whereas 17b-estradiol enhanced bcl-2 pro-
moter activity, and H2O2 plus 17b-estradiol led to basal
activity. Cyclic adenosine monophosphate (cAMP)
response element on bcl-2 promoter was responsible for
the e¡ects of 17b-estradiol and H2O2. Bcl-2 expression
was enhanced by membrane-impermeable bovine ser-
um albumin-conjugated 17b-estradiol, indicating the
e¡ects via membrane 17b-estradiol-binding sites. H2O2
decreased, whereas 17b-estradiol increased the amount
of phosphorylated cAMP response element-binding
protein and cAMP response element-dependent tran-
scriptional activity, and H2O2 plus 17b-estradiol led to
basal levels. H-89, an inhibitor of cAMP-dependent
protein kinase A, suppressed basal and 17b-estradiol-
induced cAMP response element-binding protein
phosphorylation, cAMP response element-dependent
transcriptional activity, Bcl-2 expression, and apopto-
sis resistance. The cAMP analog, dibutyryl cAMP,
enhanced cAMP response element-binding protein
phosphorylation, cAMP response element-dependent
transcriptional activity, Bcl-2 expression, and apoptosis
resistance. 17b-estradiol increased intracellular cAMP
level and protein kinase A activity, whereas these were
not altered by H2O2. Keratinocytes expressed mRNA
for estrogen receptor b and guanine nucleotide-binding
protein-coupled receptor, GPR30. GPR30 anti-sense
oligonucleotide did, but anti-sense estrogen receptor b
did not suppress 17b-estradiol-induced cAMP signal,
cAMP response element-binding protein phosphoryla-
tion, Bcl-2 expression, and apoptosis resistance. These
results suggest that 17b-estradiol may enhance Bcl-2 ex-
pression and prevent H2O2-induced apoptosis by phos-
phorylating cAMP response element-binding protein
via cAMP/protein kinase A pathway in keratinocytes.
These e¡ects of 17b-estradiol may be mediated via mem-
brane GPR30. Key words: cyclic adenosine monophosphate
response element-binding protein/GPR30/phosphorylation/pro-
tein kinaseA. J Invest Dermatol 121:1500^1509, 2003
I
thas been reported that estrogen manifests protective e¡ects
on the skin, and may aid in maintaining skin homeostasis
(Shah and Maibach, 2001). Estrogen is known to sustain
skin thickness and water-holding capacity (Shah and Mai-
bach, 2001), and also accelerates cutaneous wound healing
(Ashcroft et al, 1997). These e¡ects of estrogen are mostly exerted
by its direct action on dermal ¢broblasts; estrogen induces ¢bro-
blasts to produce transforming growth factor b1, which promotes
the maturation of ¢broblasts and synthesis of the extracellular
matrix (Ashcroft et al, 1997). On the other hand, little is known
about the direct e¡ects of estrogen on epidermal keratinocytes.
We recently found that 17b-estradiol (E2) acted on human kerati-
nocytes and inhibited their production of chemokines, IP-10,
MCP-1, and RANTES, which recruit activated T helper-1
cells or macrophages (Kanda and Watanabe, 2003a,b,c). These
results indicate that E2 may suppress the development of in£am-
matory skin diseases, such as psoriasis or lichen planus. Urano et al
(1995) also reported that E2 stimulated proliferation of human
keratinocytes; however, it has not been examined if E2 may pro-
mote the survival of keratinocytes. Keratinocytes apt to be ex-
posed to a variety of environmental or endogenous stresses, such
as oxidative stress, in£ammatory cytokines such as tumor necrosis
factor-a, ultraviolet (UV) light, or ionizing irradiation (Qin et al,
2001; Chang et al, 2002). To prevent the stress-induced apoptosis
may thus maintain the survival of keratinocytes and contribute to
skin homeostasis. Previous studies reported that E2 inhibited
staurosporine-induced apoptosis in rat cortical neurons (Honda
et al, 2001) or tumor necrosis factor-a-induced apoptosis in hu-
man breast cancer MCF-7 cells (Burow et al, 1999). On the other
hand, E2 enhanced tamoxifen-induced apoptosis in hypothala-
mic neuronal cells (Hashimoto et al, 1997). Though E2 inhibited
vitamin E succinate-induced apoptosis, it promoted spontaneous
apoptosis in MCF-7 cells (Tesarik et al, 1999). Thus E2 may either
suppress or promote apoptosis dependently on cell types or
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experimental conditions. It is reported that hydrogen peroxide,
tumor necrosis factor-a, or cell-permeable ceramides suppressed
the expression of anti-apoptotic protein Bcl-2 and thus induced
apoptosis in leukemia HL-60 or U937 cells or hippocampal neu-
rons (Chen et al, 1995; Pugazhenthi et al, 2003), whereas overex-
pression of Bcl-2 counteracted apoptosis in B-lineage cells
(Vaux et al, 1988; Alam et al, 1997). Bcl-2 prevents the activation
of caspases, inhibits membrane lipid peroxidation, and blocks
the actions of pro-apoptotic bcl-2 family members such as Bax
or Bad (Merry and Korsmeyer, 1997). Thus E2 may either sup-
press or promote apoptosis by regulating the expression of these
pro-apoptotic or anti-apoptotic bcl-2 family proteins.
It is known that the e¡ects of E2 are mediated by genomic or
nongenomic mechanisms (Beato, 1989; Kelly and Levin, 2001). E2
may thus regulate apoptosis by either or both mechanisms. The
genomic mechanism is that E2-bound nuclear estrogen receptor
(ER) a or b stimulates or inhibits gene expression by binding to
estrogen response element of the target genes or by interacting
with other transcription factors (Beato, 1989; Kanda and Wata-
nabe, 2003c). On the other hand, the nongenomic mechanism is
that E2 interacts with cell surface E2-binding sites and rapidly
induces a variety of intracellular signals (Kelly and Levin, 2001),
such as activation of adenylate cyclase (AC) (Aronica et al, 1994),
phospholipase C (Razandi et al, 1999), or extracellular signal-
regulated kinase (ERK) (Migliaccio et al, 1996). Membrane E2-
binding sites are not a unique molecule; some are post-transla-
tionally modi¢ed forms of nuclear ERa or b, whereas others are
structurally di¡erent from classical nuclear ER (Papas et al, 1995;
Razandi et al, 1999; Benten et al, 2001). It is reported that E2
interacts with several guanine nucleotide-binding protein
(G-protein)-coupled receptors such as steroid hormone-binding
globulin receptor (Fissore et al, 1994; Nakla et al, 1994), or an
orphan receptor GPR30 (Filardo et al, 2002).
In this study, we examined the in vitro e¡ects of E2 on H2O2-
induced apoptosis in human keratinocytes.We used H2O2 as an
apoptotic model as reactive oxygen species, including H2O2 are
produced and act as apoptotic regulators in keratinocytes exposed
to UV, tumor necrosis factor-a, bacteria, or viruses (Kohen and
Gati, 2000).We found that E2 prevented H2O2-induced apoptosis
in keratinocytes. We further studied the mechanism for the
e¡ects, focusing on the regulation of Bcl-2 expression by E2.
MATERIALS AND METHODS
Reagents E2-bovine serum albumin (E2-BSA) and 17a-estradiol were
purchased from Sigma (St Louis, Missouri). SQ22536, LY294002,
SB202190, PD98059, H-89, andW-7 were obtained from Calbiochem (La
Jolla, California). Monoclonal antibodies against cyclic adenosine mono-
phosphate (cAMP) response element (CRE) binding protein (CREB) and
Ser133-phosphorylated CREB were purchased from New England Biolabs
(Beverly, Massachusetts). Anti-Bcl-2 monoclonal antibody was fromTrans-
duction Laboratories (Lexington, Kentucky). Anti-glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) monoclonal antibody was from American
Research Products (Belmont, Massachusetts).
Culture of keratinocytes Human neonatal foreskin keratinocytes
were cultured in serum-free keratinocyte growth medium (Clonetics,
Walkersville, Maryland) consisting of basal medium MCDB153 supple-
mented with 0.5 mg hydrocortisone per mL, 5 ng epidermal growth factor
per mL, 5 mg insulin per mL, and 0.5% bovine pituitary extract. The cells
in third passage were used.
Assays for apoptosis Apoptosis was measured by quanti¢cation of
cytoplasmic histone-associated DNA fragments using the cell death
detection kit ELISA Plus (Roche, Indianapolis, Indiana) according to the
manufacturer’s instructions. Keratinocytes (5  103 per well) were seeded
in triplicate into 96-well plates in 200 mL of keratinocyte growth
medium, adhered overnight, then the medium was changed to phenol
red-free, basal KBM depleted of growth supplements, and incubated for
24 h. The medium was removed and the cells were incubated with 30 mM
H2O2 in the presence or absence of indicated hormones in phenol red-free
KBM for 5 h. The cell lysates were centrifuged, and the amount of
apoptotic nucleosomes in the supernatants was measured. The extent of
apoptosis was presented as enrichment factor de¢ned as absorbance at 405
nm minus absorbance at 492 nm divided by the same absorbance di¡erence
in controls with medium alone. Preliminary dose^response (10^200 mM)
and kinetic (1^10 h) experiments led to the determination of the optimal
conditions, i.e., 30 mM H2O2 for 5 h. Mitochondrial membrane potential
was measured by rhodamine 123 £uorescence as described (Sitailo et al,
2002). H2O2-treated keratinocytes were trypsinized and incubated for
20 min in KBM containing 5 mM rhodamine 123 (Sigma) at room
temperature. The cells were washed and analyzed by £ow cytometry for
reduced rhodamine 123 £uorescence, indicating loss of mitochondrial
membrane potential.
Reverse transcription^polymerase chain reaction (reverse trans-
cription^PCR) We performed semiquantitative reverse transcription^
PCR to determine relative changes in mRNA levels by densitometric
analysis. Keratinocytes were incubated as above, and total cellular RNA
was isolated using TRIzol reagent (Invitrogen, Rockville, Maryland).We
reverse-transcribed 0.5 mg of total RNA to produce cDNA as described
(Tjandrawinata et al, 1997), and 1/30 of synthesized cDNA was
thermocycled for PCR ampli¢cation with 1 mM each primer and 1.5 U of
Taq polymerase (Invitrogen). The sequences of PCR primers for ERa,
ERb, GPR30, bcl-2, bax, bcl-xL, bad, bak, and GAPDH were previously
described (Carmeci et al, 1997; Dong et al, 1999; Dubal et al, 1999; Vegeto
et al, 2001; Chernavsky et al, 2002; Kanda andWatanabe, 2003c). PCRwas
performed by one denaturing cycle of 951C for 3 min, 30 cycles of
denaturation at 951C for 30 s, annealing at 581C for 30 s, and extension at
721C for 30 s, and a ¢nal extension at 721C for 3 min. In preliminary
experiments using control cDNA from human spleen, 30 cycles lay in the
linear range of PCR ampli¢cation for each gene examined. The PCR
products were analyzed by electrophoresis on 2.5% agarose gels and
stained with ethidium bromide, viewed by UV light. Densitometric
analysis of the bands was performed by NIH Image Software. The
mRNA levels of bcl-2, bax, bcl-xL, bad, and bak were normalized for
that of GAPDH. The mRNA level for bcl-2 was further measured by
real-time quantitative reverse transcription^PCR using a TaqMan PCR
Reagent Kit (Perkin-Elmer Applied Biosystems, Foster City, California)
according to the manufacturer’s protocol. The sequences of forward and
reverse primers and TaqMan £uorogenic probe for bcl-2 and GAPDH
were previously described (Ikeguchi et al, 2002). The mRNA level of bcl-
2 was normalized for that of GAPDH.
Western blot analysis Keratinocytes incubated under the indicated
conditions were lyzed and centrifuged as described (Kanda andWatanabe,
2002). Protein concentration in the supernatant was determined by
Bio-Rad DC reagent (Bio-Rad Laboratories, Hercules, California). For
western analysis, 20 mg of proteins were resolved on a 10% sodium
dodecyl sulfate^polyacrylamide gel. The proteins were transferred to a
PVDF membrane. The membrane was blocked, and exposed to primary
antibodies, followed by peroxidase-conjugated secondary antibodies (Bio-
Rad). The blots were developed with an enhanced chemiluminescence kit
(Amersham, Arlington Heights, Illinois). Densitometric analysis of the
bands was performed by NIH Image Software.
Plasmids and transfections The ¢re£y luciferase reporter plasmids
driven by human bcl-2 P1 promoter (^1640/^1287 bp relative to the
transcriptional start site) were constructed by PCR and insertion into
pGL3 basic vector (Promega, Madison, Wisconsin) as described (Wilson
et al, 1996), and was denoted as pbcl-2 luc. Site-speci¢c mutation of the
promoter was created by multiple rounds of PCR using primers with
altered bases as described (Dong et al, 1999). p4xCRE-TATA-luc was
constructed by inserting four copies of CRE-like element (50 -
ACGTGTGACGTTACGCAC-30) from bcl-2 promoter in front of TATA
box upstream of ¢re£y luciferase reporter as described (Kanda and
Watanabe, 2003c). Transient transfections were performed with E¡ectene
(Qiagen, Tokyo, Japan) as described (Zellmer et al, 2001). The e⁄ciency of
transfection into keratinocytes by this method was mean SEM
28.5 3.1% (n¼ 9) as determined by £ow cytometry using b-galacto-
sidase vector. Keratinocytes were plated in 10 cm dishes and grown to
about 60% con£uence. Twenty-four hours before the transfection, the
medium was changed to phenol red-free KBM. Keratinocytes were
incubated for 6 h with 5 mg of pbcl-2 luc or p4xCRE-TATA-luc and 1 mg
of SV40 promoter-linked b-galactosidase reporter vector, pCH110
(Amersham), premixed with enhancer, transfection bu¡er, and E¡ectene.
The transfected cells were washed and incubated in fresh phenol red-
free KBM for 18 h, then incubated with 30 mM H2O2 in the presence
or absence of indicated hormones. After 5 h, luciferase activities of the
cell extracts were quanti¢ed by luciferase assay system (Promega). The
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same cell extracts were assayed for b-galactosidase activity using
chemiluminescent Galacto-Light kit (Tropix, Bedford, Massachusetts). All
readings were taken using a Lumat 9501 luminometer (Berthold,Wildbach,
Germany). The results obtained in each transfection were normalized for
b-galactosidase activity and expressed as relative luciferase activity. In our
preliminary experiments, H2O2 did not alter the control b-galactosidase
activity (data not shown). Human bcl-2 expression vector, pSV2-neo-bcl-2
was constructed by inserting human bcl-2 cDNA (Tsujimoto and Croce,
1986) into pSV2-neo vector as described (Fernandez et al, 1994, 1995). Ten
micrograms of the expression vector or empty vector were transfected
into 107 keratinocytes using E¡ectene as described above. After 2 d of
growth, individual bcl-2-overexpressing or control cell clones were
isolated following G418 selection (400 mg per mL for 2 wk) as described
(Fernandez et al, 1994, 1995).
Treatment with anti-sense oligodeoxynucleotides Anti-sense
oligonucleotides were synthesized as described (O’Dowd et al, 1998; Lau
et al, 2000). The oligonucleotides were ERb, 50 -CATCACAGCAGGGC-
TATA-30; GPR30, 50 -TTGGGAAGTCACATCCAT-30; random control,
50 -GATCTCAGCACGGCAAAT-30. For anti-sense experiments, keratino-
cytes were washed twice in phosphate-bu¡ered saline, then transfected,
¢nally, with 0.2 mM of the indicated oligonucleotides premixed with
Superfect Reagent (Qiagen) in phenol red-free KBM for 4 h. The medium
was aspirated and fresh medium containing E2 was added. The e⁄ciency
of transfection was 89.3 9.5% (n¼ 9) as examined microscopically using
£uorescein isothiocyanate-labeled oligonucleotides.
Measurement of cAMP amount Keratinocytes were seeded into 96-
well plates at 5  103 cells per well, adhered, and were incubated with
phenol-red free KBM for 24 h, then incubated with hormones in the
presence or absence of 30 mM H2O2 for 30 min. The medium was
discarded, and the cells were lyzed with acetate bu¡er (pH 5.8) containing
0.25% dodecyltrimethylammonium bromide. The cAMP amount in
the lysate was measured by ELISA (Amersham) according to the
manufacturer’s instructions. The sensitivity of the assay was 12 fmol per
assay well.The intracellular cAMP level was presented as pmol per 106 cells.
Assays of cAMP-dependent protein kinase A (PKA) Keratinocytes
were cultured under the indicated conditions, and were lyzed in the bu¡er
containing 20 mM Tris^HCl (pH 7.4), 1 mM ethylenediamine tetraacetic
acid, 1 mg aprotinin per mL, 1 mg pepstatin per mL, 1 mg leupeptin per
mL, 15 mM benzamidine, and 3.75 mM b-mercaptoethanol. The cell
lysate was assayed for the activity of PKA using an ELISA kit (Medical
and Biological Laboratories, Nagoya, Japan) by examining the
phosphorylation of plate-bound peptide substrate in the presence or
absence of cAMP. The absorbance at 492 nm was read, and the net
absorbance was calculated by subtracting the absorbance in the presence of
speci¢c PKA inhibitor KT-5720 (Calbiochem) from the total absorbance.
The PKA activity was expressed as an activity ratio, which is de¢ned as the
net absorbance in the absence of exogenous cAMP divided by the net
absorbance in the presence of cAMP.
RESULTS
E2 and E2-BSA prevented oxidative stress-induced apoptosis
in keratinocytes The incubation with H2O2 at 30 mM for 5 h
induced apoptosis in keratinocytes; A405^A492 in H2O2-incu-
bated cells was mean SEM 0.408 0.041 (n¼ 5), compared
with 0.037 0.005 in controls (po0.05, by paired t test), which
corresponds to enrichment factor of 11.0 1.2 in the former
group. The H2O2-induced apoptosis was suppressed by E2; the
anti-apoptotic e¡ect of E2 appeared at 10^10 M, increased in a
concentration-dependent manner, and was maximized at 10^8 M,
which reduced the apoptosis rate by 94.5%, and IC50 was 0.18 nM
(Fig 1). E2 stereoisomer 17a-estradiol did not prevent the H2O2-
induced apoptosis. E2-BSA, membrane-impermeable bovine
serum albumin-conjugated E2, suppressed the H2O2-induced
apoptosis with 0.79 nM of IC50, indicating that the e¡ect of E2
may be mediated via membrane E2-binding sites, and not via
intracellular ER. BSA alone did not alter the H2O2-induced
apoptosis. Thus E2 rescued keratinocytes from H2O2-induced
apoptosis, and the e¡ect appeared to occur at the membrane. As
apoptosis is regulated by anti-apoptotic or pro-apoptotic Bcl-2 family
members, we then examined if E2 may alter their expression.
E2 increased Bcl-2 protein and mRNA levels, and
counteracted the H2O2-induced reduction of Bcl-2
levels H2O2 decreased mRNA level of anti-apoptotic protein
Bcl-2 in keratinocytes (Fig 2a, lane 4). E2 alone increased bcl-2
mRNA level in the absence of H2O2 (lane 2), and treatment with
H2O2 plus E2 led to the control level (lane 5). E2-BSA increased
bcl-2 mRNA level (Fig 2a, lane 3), and treatment with H2O2
plus E2-BSA led to the control level (lane 6). 17a-estradiol did
not alter bcl-2 mRNA level either in the presence or absence of
H2O2 (data not shown).We further analyzed bcl-2 mRNA level
by a quantitative real-time reverse transcription^PCR (Fig 2b),
and obtained the results corresponding to those in semi-
quantitative reverse transcription^PCR (Fig 2a). In parallel with
bcl-2 mRNA level, H2O2 treatment for 5 h reduced Bcl-2
protein level (Fig 2c, lane 4). The reduction compared with
controls was 29.14.5% (n¼ 5) at 1.5 h, and was maximized to
50.3 6.4% at 4 h, as examined by Bcl-2/GAPDH ratio. The
H2O2-induced reduction of Bcl-2 protein level was associated
with the reduction of mitochondrial membrane potential; 5 h of
H2O2 treatment increased rhodamine 123 £uorescence negative
cells from 14.5 2.1% (n¼ 5) in controls to 55.6 8.3%
(po0.05, by paired t test). E2 or E2-BSA increased the Bcl-2
protein level in the absence of H2O2 (lanes 2 and 3), and
treatment with H2O2 plus E2 or E2-BSA led to control levels
(Fig 2c, lanes 5 and 6). 17a-estradiol did not alter the Bcl-2
protein level either in the presence or absence of H2O2 (data not
shown). On the other hand, E2, E2-BSA, or H2O2, either alone
or in combination, did not alter the mRNA (Fig 2a) and protein
levels (data not shown) of another anti-apoptotic Bcl-2 family
member Bcl-xL or pro-apoptotic Bax, Bad, or Bak. Thus E2 or
E2-BSA increased Bcl-2 mRNA and protein levels, and
counteracted the H2O2-induced reduction of Bcl-2 levels. The
inverse correlation of apoptosis rate with the Bcl-2 level
indicates that the increase of Bcl-2 level by E2 may rescue
keratinocytes from H2O2-induced apoptosis. This is supported
by the transfection of bcl-2 expression vector; bcl-2-overexpressed
keratinocytes were resistant to the H2O2-induced apoptosis
Figure1. Dose dependency for the e¡ects of E2 or E2-BSA on
H2O2-induced apoptosis. Keratinocytes were incubated with 30 mM
H2O2 in the presence of indicated concentrations of E2, E2-BSA, BSA, or
17a-estradiol (17a-E2). After 5 h, apoptosis was analyzed by ELISA, and
the results are shown as an enrichment factor which was de¢ned as A405^
A492 of each culture divided by the absorbance di¡erence of controls with
medium alone.Values are mean SD of triplicate cultures. po0.05 versus
cultures with H2O2 alone, by one-way ANOVA with Dunnett’s multiple
comparison test. The data shown in the ¢gure are representative of ¢ve
separate experiments.
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(Fig 3). We then examined if E2 may increase bcl-2 promoter
activity in the presence or absence of H2O2.
E2 enhanced bcl-2 promoter activity and counteracted the
H2O2-induced reduction of the activity The promoter
region of bcl-2 gene contained two GC/GA-rich sites, which
may bind Sp1 and one element (TGACGTTA) homologous to
consensus CRE (TGACGTCA), which may bind CREB (Fig
4a). These elements may act as enhancer elements for bcl-2
transcription (Dong et al, 1999). We transiently transfected bcl-2
promoter linked to luciferase reporter into keratinocytes, and
the promoter activity was evaluated by relative luciferase activity
of the cell lysates. E2 alone increased bcl-2 promoter activity (Fig
4b, uppermost six columns). H2O2 reduced bcl-2 promoter
activity, and treatment with H2O2 plus E2 led to the basal level.
Membrane-impermeable E2-BSA alone enhanced bcl-2 promoter
activity, and treatment with H2O2 plus E2-BSA led to the basal
level, whereas 17a-estradiol did not alter bcl-2 promoter activity
either in the presence or absence of H2O2 (data not shown). The
mutation of each of two Sp1 sites (Fig 4b, second and third six
columns) reduced the basal promoter activity slightly (about
20% each), but did not a¡ect the E2-induced stimulation or
H2O2-induced reduction of the activity. In contrast, the
mutation of CRE (Fig 4b, six columns at the bottom) mostly
abrogated the basal promoter activity and completely abolished
E2-induced stimulation and H2O2-induced reduction of the
activity. These results suggest that CRE may be responsible for
basal and E2-induced bcl-2 promoter activities, and may be
involved in H2O2-induced suppression of the activities.We then
analyzed if E2 may promote CRE-dependent transcriptional
activity in the presence or absence of H2O2.
E2 enhanced CRE-dependent transcriptional activity and
counteracted the H2O2-induced reduction of the activity
Keratinocytes were transiently transfected with luciferase reporter
linked to four repeats of bcl-2 promoter-derived CRE in front of
the TATA box. The luciferase activity in enhancerless TATA-
luciferase reporter-transfected keratinocytes was marginal, and
was not altered by E2 or H2O2, either alone or in combination
(data not shown). E2 alone increased CRE-dependent
transcriptional activity (Fig 5). H2O2 reduced the CRE-depen-
dent transcriptional activity, and treatment with H2O2 plus E2
led to the basal level. E2-BSA alone enhanced the CRE-
dependent transcriptional activity and treatment with H2O2 plus
E2-BSA led to the basal level (Fig 5), whereas 17a-estradiol did
not alter CRE-dependent transcriptional activity, either in the
presence or absence of H2O2 (data not shown). It is known that
phosphorylation of CREB at Ser133 promotes its transcriptional
activity on CRE (Kwok et al, 1994). The phosphorylation of CREB
recruits transcriptional coactivator CREB binding protein. The
association with CREB promotes the interaction of CREB
Figure 2. The e¡ects of E2 or E2-BSA on Bcl-2 mRNA (a,b) and
protein levels (c) in the presence or absence of H2O2. Keratinocytes
were incubated with 30 mM H2O2 or with medium alone in the presence
or absence of 10^8 M E2 or 10^7 M E2-BSA. After 5 h, total cellular RNA
or proteins were isolated. (a) PCRwas performed on cDNA from human
spleen as a positive control (Con) in parallel. (b) bcl-2 mRNA level was
measured by real-time quantitative reverse transcription^PCR, and was
normalized to the level of GAPDH. (c) The band intensity ratio of Bcl-2
versus GAPDH in western blotting was corrected to that in controls
(set as 1.0). The results shown in (a,c) are representative of ¢ve separate
experiments. The results in (b) represent mean SEM of ¢ve separate ex-
periments. po0.05 versus controls, m wpo0.05 versus H2O2 alone, by
one-way ANOVAwith Sche¡e’s multiple comparison test.
Figure 3. E¡ects of bcl-2 overexpression on H2O2-induced apopto-
sis. Keratinocytes transfected with empty vector (SV-neo) or bcl-2 expres-
sion vector were incubated with 30 mM H2O2 or medium alone. After 5 h,
apoptosis was analyzed by ELISA as described in Fig 1 legend. Values are
mean SEM (n¼ 5). po0.05 versus control cultures with medium
alone, by paired t test.
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binding protein with basal transcription factor TFIIB, and thus
facilitates CREB-mediated transcription. We then examined if
E2 may stimulate the CREB phosphorylation in keratinocytes
in the presence or absence of H2O2.
E2 enhanced CREB phosphorylation and counteracted the
H2O2-induced suppression of the phosphorylation The
amounts of phosphorylated or total CREB were analyzed by
western blotting. E2 alone increased the amount of phospho-
rylated CREB at 15 min, and the increased level was maintained
up to 3 h, followed by the slight reduction at 5 h, whereas the
amount of total CREB was not altered over the incubation period
(Fig 6, uppermost two panels). In H2O2-treated cells (Fig 6,
middle two panels), the amount of phosphorylated CREB
transiently increased at 15 min, however, became less than basal
level at 30 min, and the decreased level was maintained until 5
h, whereas the amount of total CREB did not change over the incu-
bation period. Treatment with H2O2 plus E2 resulted in the
basal level of phosphorylated CREB (Fig 6, two panels at the
bottom). E2-BSA alone increased the amount of phosphorylated
CREB, and counteracted the H2O2-induced reduction of phos-
phorylated CREB without altering the amount of total CREB,
whereas 17a-estradiol did not alter the amount of phosphorylated
CREB either in the presence or absence of H2O2 (data not shown).
PKA may be responsible for the CREB phosphorylation by
E2 It is known that CREB is phosphorylated at Ser133 by a
variety of serine/threonine kinases, such as cAMP-dependent
PKA, protein kinase C, Akt, Ca2þ/calmodulin-dependent
protein kinase type IV, mitogen-activated protein kinase
(MAPK)-activated protein (MAPKAP) kinase-2, p70S6K, or
p90rsk (Tan et al, 1996). We then analyzed which of the kinases
may be responsible for the E2-induced CREB phosphorylation,
using speci¢c kinase inhibitors. The concentrations of the
inhibitors used were decided on a basis of the reported IC50
values (Chijiwa et al, 1990; Flamigni et al, 1997; Begemann et al,
1998; Horstmann et al, 1998; Sharma et al, 1998; Miura et al, 1999;
Chen et al, 2000). These kinase inhibitors did not alter the
amount of total CREB in keratinocytes treated with medium
alone or in the presence of E2, H2O2, or both (data not shown).
H-89, a speci¢c PKA inhibitor (Fig 7a, lane 2), and SQ22536, an
inhibitor of AC, which catalyzes the synthesis of cAMP (Fig 7a,
lane 3), reduced the amount of phosphorylated CREB in
Figure 4. The e¡ects of E2 on wild-type (WT) or mutated bcl-2
promoter activities in the presence or absence of H2O2. (a) Schematic
representation of human bcl-2 promoter. The locations of putative two
Sp1-binding sites and one CRE are shown with their sequences, and sub-
stituted bases for mutation are underlined. The nucleotide positions are
relative to the transcriptional start site. (b) Keratinocytes were transiently
transfected withWTor mutated pbcl-2 luc together with pCH110, and in-
cubated with 30 mM H2O2 or with medium alone in the presence or
absence of 10^8 M E2 or 10^7 M E2-BSA for 5 h. Relative luciferase
activities normalized to b-galactosidase activities are shown. The data are
mean SEM (n¼ 4). Values at right indicate the fold induction versus
basal promoter activity. po0.05 versus values with medium alone,
wpo0.05 versus values with H2O2 alone, by one-way ANOVAwith Sche¡e’s
multiple comparison test.
Figure 5. The e¡ects of E2 or E2-BSA on CRE-dependent transcrip-
tional activity. Keratinocytes were transiently transfected with p4xCRE-
TATA-luc together with pCH110. The cells were incubated with 30 mM
H2O2 or with medium alone in the presence or absence of 10
^8 M E2 or
10^7 M E2-BSA for 5 h.The results are shown as relative luciferase activities
normalized to b-galactosidase activities, and represent mean SEM
(n¼ 4). Values at right indicate the fold induction versus basal activity.
po0.05 versus values with medium alone, wpo0.05 versus values with
H2O2 alone, by one-way ANOVAwith Sche¡e’s multiple comparison test.
Figure 6. The e¡ect of E2 on CREB phosphorylation in the pre-
sence or absence of H2O2. Keratinocytes were incubated with 30 mM
H2O2 or with medium alone in the presence or absence of 10
^8 M E2. At
indicated time-points, whole cell lysates were obtained and probed with an
antibody against phosphorylated CREB (upper panel). A parallel blot was
probed with an antibody against total CREB (lower panel). The results
shown in the ¢gure are representative of four separate experiments.
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keratinocytes treated with medium alone, E2, H2O2, or H2O2
plus E2. These results suggest that PKA may mediate both
constitutive and E2-induced CREB phosphorylation, and that
cAMP may be required for the activity of PKA. This is
supported by the fact that the cAMP analog, dibutyryl cAMP,
increased the amount of phosphorylated CREB in keratinocytes
treated with medium alone or H2O2 (Fig 7a, ¢rst and third
panels, lane 10). Dibutyryl cAMP, however, did not further
increase the amount of phosphorylated CREB in keratinocytes
treated with E2 or H2O2 plus E2 (Fig 7a, second and fourth
panels, lane 10), indicating that CREB phosphorylation by E2
and that by dibutyryl cAMP may occur via a common
mechanism, both through the activation of PKA. The amount
of phosphorylated CREB in H-89 or SQ22536 plus H2O2-
treated cells (Fig 7a, third panel, lanes 2 and 3) was lower than
that in cells treated with H-89 or SQ22536 alone (Fig 7a, ¢rst
panel, lanes 2 and 3). These results suggest that H2O2-induced
reduction of phosphorylated CREB may occur independently
from the inhibition of PKA or AC. On the other hand,
irrespective of the presence of H2O2 or E2, the amount of
phosphorylated CREB was not reduced by rapamycin, W-7, or
calphostin C (Fig 7a, lanes 4^6), which inhibits p70S6K, Ca2þ/
calmodulin-dependent protein kinase type IV, or protein kinase
C, respectively, indicating that these kinases may not be involved
in constitutive or E2-induced CREB phosphorylation. In
addition, the amount of phosphorylated CREB was not reduced
by LY294002, PD98059, or SB202190 (Fig 7a, lanes 7^9), which
inhibit phosphatidylinositol-3-OH kinase (PI-3K)/Akt, MAPK
or ERK kinase (MEK)1/ERK/p90rsk, or p38 MAPK/MAPKAP
kinase-2 signaling pathways, respectively. These results indicate
that Akt, p90rsk, or MAPKAP kinase-2 may not be involved in
constitutive or E2-induced CREB phosphorylation. In contrast,
H2O2-induced transient increase of phosphorylated CREB at 15
min (Fig 7b, lane 2) was suppressed by SB202190 (lane 4), and not
by H-89 (lane 3) or other kinase inhibitors (data not shown),
indicating that the transient CREB phosphorylation by H2O2
may be mediated by p38 MAPK/MAPKAP kinase-2 pathway,
and not by cAMP/PKA pathway.
cAMP signal induced by E2 may promote CREB-dependent
Bcl-2 expression and generate apoptosis resistance We then
analyzed if E2-induced Bcl-2 expression and apoptosis resistance
may be suppressed by PKA inhibitor, in parallel with the inhi-
bition of CREB phosphorylation. H-89 reduced CRE-dependent
transcriptional activity (Fig 8a), bcl-2 promoter activity (Fig 8b),
Bcl-2 protein level (Fig 8d), and increased apoptosis rate (Fig 8c)
in keratinocytes treated with medium alone, E2, H2O2, or E2 plus
H2O2 (lanes 2, 5, 8, and 11, respectively). An AC inhibitor SQ22536
also showed the inhibitory e¡ects similar to those of H-89 (data not
shown). Dibutyryl cAMP increased CRE-dependent transcrip-
tional activity (Fig 8a), bcl-2 promoter activity (Fig 8b), and
Bcl-2 protein level (Fig 8d) in keratinocytes treated with medium
alone or H2O2 (lanes 3 and 9, respectively), and suppressed
apoptosis in H2O2-treated cells (Fig 8c, lane 9). Dibutyryl cAMP,
however, did not further increase CRE-dependent transcriptional
activity, bcl-2 promoter activity, and Bcl-2 protein level in
keratinocytes treated with E2 or E2 plus H2O2 (lanes 6 and 12, res-
pectively), and did not reduce the apoptosis rate in these cells,
indicating a common mechanism for Bcl-2 expression by E2 and
that by dibutyryl cAMP. These results indicate that cAMP/PKA
signaling pathway may be required for both constitutive and E2-
induced Bcl-2 expression and may be responsible for the apoptosis
resistance.
We then examined if E2 may generate cAMP signal in kera-
tinocytes. At 30 min of incubation, E2 increased intracellular cAMP
level 4.1-fold of controls (Fig 9a), which was associated with the
increase of PKA activity (Fig 9b). H2O2 did not alter cAMP level
or PKA activity either in the presence or absence of E2. E2-BSA
increased cAMP level and PKA activity either in the presence or
absence of H2O2 (Fig 9a,b), whereas 17a-estradiol did not alter
cAMP level or PKA activity (data not shown). These results
suggest that E2 may increase cAMP level and resultantly promote
PKA activity in keratinocytes, whereas these may not be altered by
H2O2.
Anti-sense GPR30 suppressed E2-induced cAMP signal,
CREB phosphorylation, and Bcl-2 expression As membrane-
impermeable E2-BSA generated cAMP signal as well as E2, E2
may act on the surface of keratinocytes. It is reported that E2
induces cAMP signal by interacting with membrane-localized
ERa, ERb (Razandi et al, 1999), or GPR30 (Filardo et al, 2002).
As examined by reverse transcription^PCR, keratinocytes express-
ed ERb and GPR30 mRNA, but not that of ERa (Fig 10a),
indicating that E2 may interact with membrane-localized ERb or
GPR30 and thus generate cAMP signal. As speci¢c antibody
against GPR30 cannot be obtained, we analyzed if ERb or
GPR30 anti-sense oligonucleotides may inhibit E2-induced
cAMP signal. GPR30 anti-sense did but ERb anti-sense did not
suppress the E2-induced cAMP signal (Fig 10b), CREB
phosphorylation (Fig 10c), Bcl-2 expression (Fig 10d), and
apoptosis resistance (Fig 10e). E2-BSA-induced cAMP signal,
CREB phosphorylation, Bcl-2 expression, and apoptosis
resistance were also suppressed by GPR30 anti-sense but not by
ERb anti-sense (data not shown). These results suggest that cell
surface GPR30 may be involved in E2 or E2-BSA-induced
cAMP signal and resultant CREB phosphorylation, Bcl-2 express-
ion, and apoptosis resistance, whereas ERbmay not be involved in
these e¡ects.
DISCUSSION
In this study, E2 protected keratinocytes from H2O2-induced
apoptosis by promoting Bcl-2 expression. The bcl-2 transcription
Figure 7. The inhibition by signal inhibitors on CREB phosphory-
lation in the presence or absence of E2, H2O2, or both (a), and on
H2O2-induced transient CREB phosphorylation (b). (a) Keratinocytes
were preincubated with 1 mM H-89, 200 mM SQ22536 (SQ), 0.1 mM rapa-
mycin (Rap), 50 mM W-7, 1 mM calphostin C (CalC), 10 mM LY294002
(LY), 10 mM PD98059 (PD), or 10 mM SB202190 (SB) for 10 min, then
incubated with medium alone or with 30 mM H2O2 in the presence or
absence of 10^8 M E2 or 1 mM dibutyryl cAMP (Bt2cAMP) for another
30 min. The whole cell lysates were probed for phosphorylated CREB.
(b) Keratinocytes were preincubated with 1 mM H-89 or 10 mM SB202190
(SB) for 10 min, then incubated with 30 mM H2O2 for 15 min. The cell
lysates were immunoblotted for phosphorylated or total CREB. The
results shown are representative of ¢ve separate experiments.
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was mediated via the phosphorylation of CREB by PKA, and
PKAwas activated by cAMP signal. It is reported that cAMP-ele-
vating stimuli such as hormones or cytokines induce Bcl-2 ex-
pression and apoptosis resistance in a variety of cell types (Chen
et al, 2001; Hui et al, 2003; Koriyama et al, 2003). cAMP is gener-
ated by the stimulation of G-protein-coupled receptors linked to
the activation of AC. In keratinocytes, E2 appeared to generate
the cAMP signal via cell surface G-protein-coupled receptor,
GPR30. That is also supported by a previous study on breast can-
cer cells (Filardo et al, 2002). In the Filardo et al (2002) study, E2
induced cAMP signal in GPR30-positive SKBR3 cells, whereas
it did not in GPR30-negative MDA-MB-231 cells, and transfec-
tion of GPR30 into MDA-MB-231 restored the ability to gener-
ate cAMP signal by E2. Besides E2 generated cAMP signal
independently from ERb in their study, which is also consistent
with our present results (Fig 10). It is reported that E2 induced
bcl-2 transcription dependently on cAMP signal in MCF-7 cells
(Dong et al, 1999). E2 also increased the amounts of phosphory-
lated CREB and CREB binding protein in the nuclei of rat hip-
pocampal neurons, and these e¡ects were dependent on PKA
activity (Murphy and Segal, 1997). These studies, however, did
not clarify if GPR30 may mediate the e¡ects of E2. Besides it
has not been studied if GPR30 may regulate apoptosis or Bcl-2
expression via CREB phosphorylation.Thus this is the ¢rst study
that supports GPR30-mediated Bcl-2 expression and apoptosis
resistance. GPR30 is a 375 amino acid G-protein-coupled recep-
tor with seven transmembrane domains (Carmeci et al, 1997). The
ligand for GPR30 has not been identi¢ed yet, but may be a
certain peptide or glycoprotein (Carmeci et al, 1997). GPR30
mRNA is expressed ubiquitously in brain, lung, liver, prostate,
or colon (Owman et al, 1996). Thus GPR30 may generally induce
apoptosis resistance in a variety of tissues, and this possibility
should further be examined.
As activation of GPR30-generated cAMP signal, GPR30 may
possibly be linked to AC via Gs. It is hypothesized that the bind-
ing of E2 may activate GPR30 and induce the dissociation of the
receptor-coupled G-protein heterotrimers, possibly Gsabg, into
Figure 8. The inhibition by PKA inhibitor on CRE-dependent transcriptional activity (a), bcl-2 promoter activity (b), apoptosis resistance
(c), and Bcl-2 protein level (d) in the presence or absence of E2, H2O2, or both. (a,b) Keratinocytes were transiently transfected with p4xCRE-
TATA-luc (a) or pbcl-2 luc (b), together with pCH110, then preincubated with 1 mM H-89 for 10 min, then incubated with medium alone or with 30 mM
H2O2 in the presence or absence of 10
^8 M E2 or 1 mM dibutyryl cAMP (Bt2cAMP) for another 5 h. Luciferase activities of the cell lysates were analyzed
and were normalized to b-galactosidase activities. (c,d) Keratinocytes without transfection were incubated as above, and apoptosis (c) or Bcl-2 protein level
(d) were analyzed. (a^c) Values are mean SEM of ¢ve separate experiments. po0.05 versus values with medium alone, wpo0.05 versus values with E2
alone, zpo0.05 versus values with H2O2 alone, ypo0.05 versus values with H2O2 plus E2, by one-way ANOVAwith Sche¡e’s multiple comparison test. The
results shown in (d) are representative of ¢ve separate experiments.
Figure 9. The e¡ects of E2 or E2-BSA on the intracellular cAMP
level (a) and PKA activity (b) in the presence or absence of H2O2.
Keratinocytes were incubated with 30 mM H2O2 or with medium alone in
the presence or absence of 10^8 M E2 or 10^7 M E2-BSA for 30 min. The
intracellular cAMP level (a) or PKA activity of the cell lysates (b) were
analyzed. The data represent the mean SEM of four separate experi-
ments. po0.05 versus values with medium alone, by one-way ANOVA
with Sche¡e’s multiple comparison test.
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Gsa and Gbg, the former of which may stimulate AC catalytic
subunit. E2 stereoisomer, 17a-estradiol did not induce cAMP sig-
nal in keratinocytes, which is consistent with a previous study on
GPR30-transfected MDA-MB-231 cells (Filardo et al, 2002).We
also found that ER antagonists, ICI 182 780 and 4-hydroxyta-
moxifen induced cAMP signal, CREB phosphorylation, bcl-2
expression, and prevented H2O2-induced apoptosis in keratino-
cytes, and these e¡ects were suppressed by anti-sense GPR30
(data not shown). Filardo et al (2002) also reported that these
anti-estrogens generated cAMP signal in GPR30-transfected
MDA-MB-231 cells. Thus tamoxifen derivatives or ICI com-
pounds may act as agonists for membrane GPR30, whereas 17a-
estradiol may not.
The phosphorylation of CREB at Ser133 is induced by various
signaling pathways activating serine/threonine kinases, such as PI-
3K/Akt, phospholipase C/protein kinase C, MEK/ERK/p90rsk,
PI-3K/p70S6k, p38 MAPK/MAKAP kinase-2 pathways, or
Ca2þ/calmodulin-dependent protein kinase IV, in addition to
cAMP/PKA pathway (Tan et al, 1996). Cell types or stimuli may
in£uence which of these signals dominantly induces CREB
phosphorylation. In keratinocytes, PKA may mainly mediate the
constitutive and E2-induced CREB phosphorylation. In rat cor-
tical neurons, E2 enhanced Bcl-2 expression via PI-3K/Akt-
mediated CREB phosphorylation (Honda et al, 2001). The activa-
tion of the PI-3K/Akt pathway by E2, however, is rather unlikely
in keratinocytes lacking ERa as PI-3K can be activated by E2-
bound ERa but not by ERb (Simoncini et al, 2000). In the cell
types other than keratinocytes, E2 induced intracellular Ca2þ
signal (Benten et al, 2001), activated phospholipase C/protein ki-
nase C pathway (Le Mellay et al, 1999), or activated the src/Ras/
MEK/ERK pathway (Migliaccio et al, 1996), all of which may be
relevant to CREB phosphorylation. In keratinocytes, however,
these E2-induced signals may not occur, or may be insu⁄cient,
if any, for CREB-dependent bcl-2 transcription, possibly because
the magnitude of the signals may be small and/or their duration
may be short. Previous study also reported that CREB-depen-
dent gene transcription needs sustained CREB phosphorylation
in the order of hours (Schultz et al, 1999). H2O2 induced transient
CREB phosphorylation (p15 min), and this appeared to be
mediated by the p38 MAPK/MAPKAP-kinase 2 pathway. The
transient activation of p38 MAPK by H2O2 was also reported in
rat pheochromocytoma PC12 cells (Zhang and Jope, 1999), and
may be a protective response to stress, however, without a parallel
increase in Bcl-2 expression. On the contrary, more than 30 min
of incubation with H2O2 reduced the amount of phosphorylated
CREB in keratinocytes (Fig 6), whereas H2O2 did not suppress
PKA activity (Fig 9). It is thus indicated that H2O2 may reduce
the amount of phosphorylated CREB by a PKA-independent
mechanism; H2O2 may activate serine/threonine phosphatases
that dephosphorylate and inactivate the phosphorylated CREB.
It is reported that protein phosphatase 1 directly dephosphorylates
the phosphorylated CREB and that protein phosphatase 2B en-
hances the activity of protein phosphatase 1 by dephosphorylating
and inactivating an inhibitory subunit of protein phosphatase 1
(Bito et al, 1996). In keratinocytes, H2O2 may activate either or
both of these phosphatases, and thus reduce the amount of phos-
phorylated CREB. Previous studies also suggested that H2O2
may activate protein phosphatase 1 in murine cerebellar granule
Figure10. ERb and GPR30 mRNA expression in keratinocytes (a)
and the inhibition by GPR30 anti-sense oligonucleotide on E2-in-
duced cAMP signal (b), CREB phosphorylation (c), Bcl-2 protein
expression (d), and apoptosis resistance (e). (a) PCR was performed
with cDNA from keratinocytes (KC) and from breast cancer MCF-7 cells
as positive controls (Con). (b^d) Keratinocytes were transfected with
0.2 mM of indicated anti-sense (AS) or control scrambled oligonucleotides
(ODN) for 4 h. The medium was changed and the cells were incubated
with 30 mM H2O2 or with medium alone in the presence or absence of
10^8 M E2. The intracellular cAMP level (b) and CREB phosphorylation
(c) were analyzed at 30 min, whereas Bcl-2 protein level (d) and apoptosis
(e) were evaluated at 5 h. (b,e) Values are mean SEM of ¢ve separate
experiments. po0.05 versus values with medium alone, wpo0.05 versus va-
lues with H2O2 alone, zpo0.05 versus values with H2O2 plus E2, by one-
wayANOVAwith Sche¡e’s multiple comparison test. The results shown in
(a,c,d) are representative of ¢ve separate experiments.
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neurons (See and Loe¥er, 2001) or sheep erythrocytes (Bize and
Dunham, 1995; Bize et al, 1998).
In addition to CRE, two GC/GA-rich elements on the bcl-2
promoter acted as E2-inducible enhancer elements in MCF-7
cells (Dong et al, 1999). These two elements, however, were not
responsible for E2-induced bcl-2 transcription in keratinocytes
(Fig 4). The di¡erence is possibly due to the absence of ERa in
keratinocytes. E2-bound ERa can interact with Sp1 and enhance
its DNA binding and transcriptional activity, however, ERb can-
not promote the activity of Sp1 (Safe, 2001; Kanda andWatanabe,
2003c).
E2 is reported to suppress apoptosis independently of Bcl-2
in the cell types di¡erent from keratinocytes. E2 enhanced the
expression of another anti-apoptotic protein Bcl-xL in cultured
hippocampal neurons (Pike, 1999) or suppressed the expression
of pro-apoptotic Bak in MCF-7 cells (Leung and Do LinhWang,
1998). At least in mRNA and protein levels, E2 did not alter the
expression of these anti-apoptotic or pro-apoptotic proteins in
keratinocytes (Fig 2). E2 also inhibits membrane phospholipid
peroxidation and acts as an anti-oxidant (Sugioka et al, 1987). E2
suppressed H2O2-induced apoptosis in murine hippocampal
HT22 cells via its anti-oxidant capacity (Behl et al, 1995, 1997).
In Behl et al ’s (1995) study, however, higher concentrations of E2
(about 10^5 M) are needed for the anti-apoptotic e¡ect and 17a-
estradiol also suppressed H2O2-induced apoptosis via anti-oxi-
dant capacity, which is inconsistent with our present results (Fig
1). Thus the anti-oxidant activity of E2 may not be relevant to the
anti-apoptotic e¡ect exerted at 10^8 M in this study.
Our present results support that E2 may rescue keratinocytes
from oxidative stress-induced apoptosis. H2O2 is generated in
keratinocytes by UVB irradiation, and acts as an apoptotic med-
iator (Peus et al, 1999). Our results thus indicate that E2 may pro-
tect keratinocytes from UVB-induced apoptosis and thus can be
prophylactically applied to the skin before sun exposure. Bianchi
et al (1994) reported that skin in£ammatory diseases such as psor-
iasis or lichen planus were associated with abnormally increased
apoptosis and the reduction of Bcl-2 levels in basal keratinocytes,
and suggested a central role for apoptosis in the pathogenesis of
these diseases. Thus topical application of E2 may be therapeuti-
cally e¡ective for these skin lesions by restoring Bcl-2 levels and
by preventing the aberrant apoptosis in the lesional keratinocytes.
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